ConductScience.org, home

Paper986124

Clinical pharmacokinetics of sisomicin: dosage schedules in renal-impaired patients.

Pechère JC and 2 others. Antimicrob Agents Chemother, 1976. Cited by 15 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Clinical pharmacokinetics of sisomicin: dosage schedules in renal-impaired patients. Papers, record 986124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/986124

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical pharmacokinetics of sisomicin: dosage schedules in renal-impaired patients.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.98
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pechère JCJ C
2Pechère MMM M
3Dugal RR

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Kidney Failure, ChronicMajor topic
SisomicinMajor topic
Adult
Aged
Biological Assay
Blood Urea Nitrogen
Female
Half-Life
Humans
Kinetics
Male
Middle Aged
Renal Dialysis

Source PubMed

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115,825,423In vitro comparison of four aminoglycoside antibiotics: sisomicin, gentamicin, tobramycin, and BB-K8.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/15825423PubMed
24,214,702Antipseudomonal drugs: comparative study of gentamicin, sisomicin and tobramycin in vitro and in human volunteers.Eur J Cancer (1965)1973https://conductscience.org/library/papers/4214702PubMed
34,610,017Sisomicin treatment of complicated urinary tract infections: efficacy, tolerance and pharmacokinetics.J Clin Pharmacol1974https://conductscience.org/library/papers/4610017PubMed
44,790,579In vitro bactericidal effectiveness of four aminoglycoside antibiotics.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4790579PubMed
54,790,572Sisomicin: evaluation in vitro and comparison with gentamicin and tobramycin.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4790572PubMed
64,790,568Tobramycin and gentamicin concentrations in the serum of normal and anephric patients.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4790568PubMed
74,670,437Comparative activity of sisomicin, gentamicin, kanamycin, and tobramycin.Antimicrob Agents Chemother1972https://conductscience.org/library/papers/4670437PubMed
84,959,982Simplified, accurate method for antibiotic assay of clinical specimens.Appl Microbiol1966https://conductscience.org/library/papers/4959982PubMed
91,137,357Clinical pharmacology of sisomicin.Antimicrob Agents Chemother1975https://conductscience.org/library/papers/1137357PubMed
105,121,528Renal excretion of gentamycin in chronic pyelonephritis.Acta Med Scand1971https://conductscience.org/library/papers/5121528PubMed

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
1,804,011Isepamicin disposition in subjects with various degrees of renal function.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1804011PubMed
708,018Pharmacokinetics of netilmicin in patients with renal impairment and in patients on dialysis.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/708018PubMed
699,461Pharmacokinetics of netilmicin in renal insufficiency and haemodialysis.Clin Pharmacokinet1978https://conductscience.org/library/papers/699461PubMed
666,299Clinico-pharmacological studies of sisomicin in ill children.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/666299PubMed
467,467Pharmacokinetics of intravenous amikacin after rapid and slow infusion with special reference to hemodialysis.Eur J Drug Metab Pharmacokinet1979https://conductscience.org/library/papers/467467PubMed
383,354Clinical pharmacokinetics of aminoglycoside antibiotics.Clin Pharmacokinet1979https://conductscience.org/library/papers/383354PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/986124

GET https://conductscience.org/api/papers/v1/986124/authors